Johnson & Johnson To Stop Selling Talc-Containing Baby Powder in U.S. & Canada

As reported by The Wall Street Journal, health-products giant Johnson & Johnson has announced that it will discontinue the sale of its talc-containing Johnson’s Baby Powder in the U.S. and Canada, citing lowered sales in the wake of widespread litigation over alleged links between the powder and ovarian cancer in women who used the product for

2020-05-19T16:34:33+00:00May 19th, 2020|Personal Injury|
Read More

Zantac Ordered Off Store Shelves Over Cancer Risks

FDA mandates halt to distribution of ranitidine (Zantac) due to potentially carcinogenic contamination After previously warning consumers and doctors last September that it had found measurable amounts of the carcinogen NDMA (N-notrisodimethylamine) in samples of the widely-used heartburn medication Zantac, the U.S. Food and Drug Administration has now ordered manufacturers to immediately stop distributing all

2020-04-02T08:22:00+00:00April 2nd, 2020|Prescription Drug Injuries|
Read More

Title